Sydney compliance startup Haast raises $17m Series A, no sales hires announced
Sydney-founded Haast closed a US$12 million ($17m AUD) Series A led by Peak XV Partners, with DST Global Partners, Airtree, Aura Ventures, and Black Sheep Capital participating. Total raise sits at US$17.05 million across three rounds since 2022.
The company automates marketing compliance reviews for regulated industries: telcos, insurance, finance. Clients include Telstra, Zurich Australia & New Zealand, Aviva, and Future Super. Haast reports 80% reduction in manual reviews and 3x faster approvals for some customers.
Revenue grew 4.5x in 12 months with zero churn among Fortune 500 accounts. Base revenue number is not disclosed.
What this means for sales teams
Haast positions as compliance infrastructure embedded in workflows, not a point solution. If you are selling into enterprises with legal review bottlenecks (financial services, telecom, insurance), this is a competitor or partner depending on your stack.
The funding announcement mentions US expansion and team growth, but no specifics on sales hiring. No CRO, VP Sales, or AE headcount disclosed. For a $17m raise targeting Fortune 500 accounts, that is notable. Either the motion is heavily product-led or channel-driven, or they are keeping sales expansion plans quiet.
Founders are CEO Kunal Vankadara, Jason Watling, and Liam King. No other C-suite named publicly.
The compliance automation market
Haast competes in the growing AI compliance software category: tools that automate regulatory reviews, policy checks, and risk assessments for AI-generated content. Adjacent to sales enablement compliance tools (think: approved messaging libraries, regulated claims automation) but focused upstream on marketing production.
For sales teams in regulated industries, compliance review delays kill deals. If marketing cannot ship approved collateral, AEs wait. Haast's pitch is that they remove that bottleneck by automating legal and compliance sign-off.
Worth noting: they relocated headquarters to New York but maintain ANZ roots and clients. Series A timing (April 2026) suggests they are scaling aggressively into US enterprise accounts.
No competitor names disclosed in public materials. Revenue multiples, burn rate, and quota attainment data are not available.